Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    27-March-2001      
Issue 86 Next Update - 14:00 UTC 08:00 EST    28-March-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya

Back To Vidyya Today In Vidyyasm

Vidyya Medical News Service For 27-March-2001:

The following stories appear in full on Today's Vidyya Medical News Service Web site.

An international study published Friday, 23 March 2001 in The Lancet shows that a well established drug -- fenofibrate -- significantly reduces the risk of atherosclerosis -- the leading cause of potentially fatal events in millions of people with type 2 diabetes.

For more information: Fenofibrate Significantly Reduces Risk Of Atherosclerosis

Six children have died of measles and 15 others are in critical condition after an outbreak of measles in Ugandan capital Kampala. Elsewhere, the World Health Organization has received preliminary reports of 23 hospitalized cases of plague, including 3 deaths in Petauke district of Zambia.

For more information: Measles Toll Reaches Six In Ugandan Capital: Plague Reported In Zambia

NIDDK scientists and their collaborators have discovered that a protein called M3 muscarinic acetylcholine receptor helps regulate how much animals eat. The findings, which appear in the 8 March 2001, issue of Nature, highlight just how complex the brain chemistry governing food intake is.

For more information: NIDDK Team Uncovers A Novel Pathway That Controls Eating

Fenofibrate lowers elevated serum lipids by decreasing the low density lipoprotein (LDL) fraction rich in cholesterol and the very low density lipoprotein (VLDL) fraction rich in triglycerides. In addition, fenofibrate increases the high density lipoprotein (HDL) cholesterol fraction. Fenofibrate appears to have a greater depressant effect on the very low density lipoproteins (VLDL) than on the low density lipoproteins (LDL). Therapeutic doses of fenofibrate produce variable elevations of HDL cholesterol, a reduction in the content of the total low density lipoproteins cholesterol, and a substantial reduction in the triglyceride content of very low density lipoproteins.

For more information: Prescribing Information: Fenofibrate (Lipidil ®)

The United States has aggressive BSE surveillance and prevention programs in place. FDA's restrictions on certain animal feed ingredients and its import alerts on cattle products are a critical part of this program. In addition, USDA has an import ban on certain cattle and cattle products, and CDC has established surveillance and investigation programs for suspected human TSE cases. USDA's Animal and Plant Health Inspection Service (APHIS) introduced import restrictions in 1989, when it banned the import of all live ruminants (cud-chewing animals, such as cows, sheep, and goats) from the UK.

For more information: BSE: Background, Current Concerns, And US Response

Today's Vidyya articles are:

As always, we hope you enjoy the issue.

Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 
Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.